| 5.15.2013 | GALT | Galectin Therapeutics to Hold Conference Call to Provide Update Following Company’s Annual Meeting of Shareholders |
| 5.10.2013 | GALT | Galectin Therapeutics Reports First Quarter 2013 Financial Results |
| 4.29.2013 | GALT | Galectin Inhibitors Reverse Liver Cirrhosis in Preclinical Studies |
| 4.17.2013 | GALT | Galectin Therapeutics to Present New Data on the Treatment of Liver Fibrosis and Cirrhosis |
| 4.9.2013 | GALT | Clinical Trial Sites for First Human Clinical Trial for Treatment of Fatty Liver Disease with Advanced Fibrosis Announced by Galectin Therapeutics |
| 3.5.2013 | GALT | Galectin Therapeutics Inc. Receives OK from FDA to Proceed with First Human Clinical Trial for Treatment of Fatty Liver Disease with Advanced Fibrosis |
| 2.19.2013 | GALT | Galectin Therapeutics Announces Discovery Program for New Anti-Galectin Drugs in Collaboration with the University of Georgia |
| 2.1.2013 | GALT | Galectin Submits IND For GR-MD-02 |
| 1.31.2013 | GALT | Galectin Therapeutics Inc. Announces Submission of an Investigational New Drug (IND) Application for the Treatment of Fatty Liver Disease |
| 1.29.2013 | GALT | GALT To Be Featured On New Show On Fox Business News |
| 1.22.2013 | GALT | New Potential Therapy for Diabetic Kidney Disease: Galectin Therapeutics Announces Anti-Galectin Drug is Effective in Preclinical Studies |